Given that NF-κB affects almost the entire arsenal of immune guardians and immune cells (1), special concern has gradually been focused on the pivotal role of NF-κB dysregulation in many autoimmune inflammatory diseases including multiple sclerosis (MS), systemic lupus erythematosus, and type 1 diabetes. The gene discussed is NFKB1; the disease is myeloid sarcoma.